Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glyburide vs Glucovance in the Treatment of Gestational Diabetes

NCT02726490 is registered in ClinicalTrials.gov with Texas Tech University Health Sciences Center, El Paso as lead sponsor.

NCT NCT02726490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02726490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glyburide vs Glucovance in the Treatment of Gestational Diabetes
Lead sponsor
Texas Tech University Health Sciences Center, El Paso
Phase
Phase 1
Overall status
Terminated
Start date
July 31, 2016
Completion date
August 14, 2018
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes